trending Market Intelligence /marketintelligence/en/news-insights/trending/7n2m4nefohfwwkzjphjzha2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Dipexium Pharmaceuticals names chief medical officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Dipexium Pharmaceuticals names chief medical officer

New York-based drugmaker Dipexium Pharmaceuticals Inc. appointed Efthymios Deliargyris as chief medical officer.

Deliargyris was previously the chief medical adviser of the company.

Dipexium Pharmaceuticals is a late-stage pharmaceutical company, engaging in the development and marketing of antibiotics in the U.S.